A detailed history of Vanguard Group Inc transactions in Uni Qure N.V. stock. As of the latest transaction made, Vanguard Group Inc holds 1,234,946 shares of QURE stock, worth $7.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,234,946
Previous 1,161,528 6.32%
Holding current value
$7.04 Million
Previous $5.2 Million 17.01%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.78 - $10.12 $277,520 - $742,990
73,418 Added 6.32%
1,234,946 $6.09 Million
Q2 2024

Aug 13, 2024

BUY
$4.39 - $5.43 $390,674 - $483,226
88,992 Added 8.3%
1,161,528 $5.2 Million
Q1 2024

May 10, 2024

BUY
$4.82 - $6.93 $528,946 - $760,498
109,740 Added 11.4%
1,072,536 $5.58 Million
Q4 2023

Feb 14, 2024

BUY
$5.63 - $8.27 $52,696 - $77,407
9,360 Added 0.98%
962,796 $6.52 Million
Q3 2023

Nov 14, 2023

SELL
$6.71 - $11.83 $2.96 Million - $5.23 Million
-441,830 Reduced 31.67%
953,436 $6.4 Million
Q2 2023

Aug 14, 2023

SELL
$11.12 - $22.2 $160,128 - $319,680
-14,400 Reduced 1.02%
1,395,266 $16 Million
Q1 2023

May 15, 2023

SELL
$18.7 - $23.07 $33,566 - $41,410
-1,795 Reduced 0.13%
1,409,666 $28.4 Million
Q4 2022

Feb 10, 2023

SELL
$18.12 - $27.32 $408,479 - $615,874
-22,543 Reduced 1.57%
1,411,461 $32 Million
Q3 2022

Nov 14, 2022

BUY
$16.98 - $25.54 $2.4 Million - $3.61 Million
141,382 Added 10.94%
1,434,004 $26.9 Million
Q2 2022

Aug 12, 2022

BUY
$13.15 - $20.45 $1.09 Million - $1.69 Million
82,782 Added 6.84%
1,292,622 $24.1 Million
Q1 2022

May 13, 2022

BUY
$14.54 - $21.5 $436,970 - $646,139
30,053 Added 2.55%
1,209,840 $21.9 Million
Q4 2021

Feb 14, 2022

SELL
$20.24 - $36.01 $181,694 - $323,261
-8,977 Reduced 0.76%
1,179,787 $24.5 Million
Q3 2021

Nov 12, 2021

BUY
$26.01 - $38.22 $12 Million - $17.6 Million
461,190 Added 63.39%
1,188,764 $38.1 Million
Q2 2021

Aug 13, 2021

BUY
$29.97 - $37.17 $21.8 Million - $27 Million
727,574 New
727,574 $22.4 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $266M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.